ArticleTherapeutic innovation & regulatory science2025

Cross-sectional Study and Comparison between Japan and the United States on Special Regulatory Pathways for Expedited Drug Development and Approval.

Kojiro Kobayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.